One randomized trial showed that vitamin D supplementation (4000 IU/day) in patients with low-grade prostate cancer reduced the increase in PSA (prostate-specific antigen) levels, suggesting a possible beneficial effect [28]. This evidence concerns the gene KLK3 and prostate carcinoma.